Patent Assignment
Reel/Frame 048540/0415
Corrective Assignment to Correct the Assignee Name Previously Recorded at Reel: 044166 Frame: 0008. Assignor(S) Hereby Confirms the Security Interest.
Recorded: 2019-03-08
Pages: 8
Assignor
RECRO PHARMA, INC.
Executed: 2017-11-17
Assignee
ATHYRIUM OPPORTUNITIES III ACQUISITION LP
530 FIFTH AVENUE, FLOOR 25, C/O ATHYRIUM CAPITAL MANAGEMENT LP, NEW YORK, NEW YORK, 10036
Covered Properties
(10)
Imidazol Derivatives Having Affinity for Alpha 2 Receptors Activity
Intermediate Duration Neuromuscular Blocking Agents and Antagonists Thereof
Treatment or Prevention of Hypotension and Shock
Reversible Nondepolarizing Neuromuscular Blockade Agents and Methods for Their Use
Cysteine for Physiological Injection
Intranasal Dexmedetomidine Compositions and Methods of Use Thereof
Treatment or Prevention of Hypotension and Shock
Asymmetrical Reversible Neuromuscular Blocking Agents of Ultra-Short, Short, or Intermediate Duration
Treatment Or Prevention Of Hypotension And Shock
Intranasal Dexmedetomidine Compositions And Methods Of Use Thereof
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 15, 2012
From: SAVARESE, JOHN J.; HEERDT, PAUL M.
To: CORNELL UNIVERSITY
Reel/Frame 028215/0105 →
Assignment of Assignor's Interest
Jul 16, 2013
From: HEINO, RIITTA; LEINO, TIINA; LEHTIMAKI, TARJA
To: ORION CORPORATION
Reel/Frame 030801/0871 →
Assignment of Assignor's Interest
Jul 16, 2013
From: ORION CORPORATION
To: RECRO PHARMA, INC.
Reel/Frame 030801/0881 →
Assignment of Assignor's Interest
Sep 27, 2013
From: HEINO, RIITTA; LEINO, TIINA; LEHTIMAKI, TARJA
To: ORION CORPORATION
Reel/Frame 031300/0565 →
Assignment of Assignor's Interest
Oct 16, 2013
From: HENWOOD, GERALDINE A.; MACK, RANDALL J.; KOLENG, JOHN JOSEPH, JR.; SHARR, CHRISTOPHER T.
To: RECRO PHARMA, INC.
Reel/Frame 031415/0268 →
Assignment of Assignor's Interest
Nov 8, 2013
From: RECRO PHARMA, INC.
To: MALVERN CONSULTING GROUP, INC.
Reel/Frame 031571/0794 →
Corrective Assignment to Correct the Assignor and Assignee Information and Remove the Additional Property Previously Recorded on Reel 031571 Frame 0794. Assignor(S) Hereby Confirms the Correct Assignor Is Malvern Consulting Group, Inc. and the Correct Assignee Is Recro Pharma, Inc.
Nov 12, 2013
From: MALVERN CONSULTING GROUP, INC.
To: RECRO PHARMA, INC.
Reel/Frame 031626/0634 →
Security Interest
Apr 14, 2015
From: RECRO PHARMA, INC.
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 035403/0197 →
Assignment of Assignor's Interest
May 26, 2015
From: ORION CORPORATION
To: RECRO PHARMA, INC.
Reel/Frame 035706/0785 →
Assignment of Assignor's Interest
Nov 17, 2015
From: ORION CORPORATION
To: RECROPHARMA, INC.
Reel/Frame 037054/0708 →
Assignment of Assignor's Interest
Nov 17, 2015
From: HEINO, RIITTA; LEINO, TIINA; LEHTIMAKI, TARJA
To: ORION CORPORATION
Reel/Frame 037054/0614 →
Assignment of Assignor's Interest
Oct 6, 2017
From: MALVERN CONSULTING GROUP, INC.
To: RECRO PHARMA, INC.
Reel/Frame 043804/0083 →
Assignment of Assignor's Interest
Oct 6, 2017
From: HENWOOD, GERALDINE A.; MACK, RANDALL J.; KOLENG, JR., JOHN JOSEPH; SHARR, CHRISTOPHER T.
To: RECRO PHARMA, INC.
Reel/Frame 043804/0010 →
Corrective Assignment to Correct the Fifth Inventor Name Previously Recorded at Reel: 043804 Frame: 0010. Assignor(S) Hereby Confirms the Assignment.
Oct 9, 2017
From: HENWOOD, GERALDINE A.; MACK, RANDALL J.; KOLENG, JR., JOHN JOSEPH; SHARR, CHRISTOPHER T.
To: RECRO PHARMA, INC.
Reel/Frame 044150/0674 →
Security Interest
Nov 17, 2017
From: RECRO PHARMA, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUSITION LP
Reel/Frame 044166/0008 →
Release of Security Interest
Nov 17, 2017
From: ORBIMED ROYALTY OPPORTUNITIES II, LP
To: RECRO PHARMA, INC.
Reel/Frame 044481/0907 →
Assignment of Assignor's Interest
Jan 30, 2020
From: RECRO PHARMA, INC.
To: BAUDAX BIO, INC.
Reel/Frame 051671/0536 →
Security Interest
Jun 10, 2020
From: BAUDAX BIO N.A. LLC; BAUDAX BIO LIMITED; BAUDAX BIO, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 052891/0590 →
Release of Security Interest
Dec 16, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: SOCIETAL CDMO, INC.
Reel/Frame 062123/0184 →